Clincosm LogoSign in Get a demo

bladder cancer

Showing NaN - NaN of 115
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Invasive Ductal Breast Carcinoma, Invasive Ductal Breast Carcinoma Stage IV, Lobular Breast Carcinoma Trial in United States

Recruiting
  • Invasive Ductal Breast Carcinoma
  • +14 more
  • Stereotactic body radiotherapy
  • Lattice Radiation Therapy
  • Basking Ridge, New Jersey
  • +6 more
Apr 20, 2023

Bladder Cancer Trial in Worldwide (TAR-200, Cetrelimab, BCG Vesiculture)

Not yet recruiting
  • Bladder Cancer
  • Scottsdale, Arizona
  • +241 more
Feb 9, 2023

Urothelial Carcinoma, Bladder Cancer Trial in United States (drug, radiation, biological)

Recruiting
  • Urothelial Carcinoma
  • Bladder Cancer
  • Durvalumab (Cohort 1-3)
  • +7 more
  • Phoenix, Arizona
  • +10 more
Jan 11, 2023

NSCLC, Gastric Carcinoma, Gastroesophageal Junction Carcinoma Trial in Worldwide (SEA-TGT, sasanlimab)

Recruiting
  • Non-small Cell Lung Cancer
  • +11 more
  • Birmingham, Alabama
  • +32 more
Jan 4, 2023

Melanoma, NSCLC, Bladder Cancer Trial in Worldwide (Autogene cevumeran, Atezolizumab)

Active, not recruiting
  • Melanoma
  • +7 more
  • Scottsdale, Arizona
  • +36 more
Dec 22, 2022

Non-muscle Invasive Bladder Cancer, NMIBC, Carcinoma in Situ of Bladder Trial in United States (UGN-301, UGN-201)

Recruiting
  • Non-muscle Invasive Bladder Cancer
  • +5 more
  • Little Rock, Arkansas
  • +7 more
Dec 19, 2022

Quality of Life in Patients With Bladder Cancer

Active, not recruiting
  • Bladder Cancer
  • Quality Of Life questionnaires
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Dec 8, 2022

Bladder Cancer Trial in Worldwide (Atezolizumab)

Active, not recruiting
Has Results
  • Bladder Cancer
  • Birmingham, Alabama
  • +76 more
Dec 6, 2022

Bladder Cancer Trial in Worldwide (Atezolizumab)

Active, not recruiting
Has Results
  • Bladder Cancer
  • Birmingham, Alabama
  • +76 more
Dec 6, 2022

Fragments for Early Interception - Lung Cancer Training Study

Recruiting
  • Lung Cancer
  • +8 more
  • Blood Sample Collection
  • New York, New York
  • +1 more
Nov 28, 2022

Intravesical Therapy and Surgery as Treatment Options for

Recruiting
  • Bladder Cancer
  • +2 more
    • Birmingham, Alabama
    • +37 more
    Nov 28, 2022

    Bladder Cancer, Metastatic Bladder Cancer, Urothelial Carcinoma Trial in United States (Atezolizumab, Gemcitabine, Cisplatin)

    Active, not recruiting
    • Bladder Cancer
    • +2 more
    • Hartford, Connecticut
    • +10 more
    Nov 23, 2022

    Metastatic Cancer, Melanoma Cancer, Lung Cancer Trial in United States (Stereotactic Body Radiotherapy, Ipilimumab, Nivolumab,

    Recruiting
    • Metastatic Cancer
    • +5 more
    • Stereotactic Body Radiotherapy
    • Ipilimumab, Nivolumab, Pembrolizumab or Atezolizumab
    • Hartford, Connecticut
    • +9 more
    Nov 17, 2022

    Renal Cell Cancer, Melanoma, Non-Small-Cell Lung Cancer Trial in Duarte, Louisville, New York (PF-07263689, Sasanlimab)

    Active, not recruiting
    • Renal Cell Cancer
    • +9 more
    • PF-07263689
    • Sasanlimab
    • Duarte, California
    • +5 more
    Nov 8, 2022

    Bladder Cancer Trial in United States (Nivolumab, Nivolumab/Lirilumab)

    Completed
    Has Results
    • Bladder Cancer
    • Tampa, Florida
    • +7 more
    Nov 4, 2022

    Bladder Cancer Trial in United States (N-803 and BCG, N-803)

    Recruiting
    • Bladder Cancer
    • Anchorage, Alaska
    • +31 more
    Oct 26, 2022

    Prostate Cancer, Bladder Cancer, NSCLC Trial in New York, Houston (NY-ESO-1 Plasmid DNA Cancer Vaccine)

    Completed
    Has Results
    • Prostate Cancer
    • +4 more
    • NY-ESO-1 Plasmid DNA Cancer Vaccine
    • New York, New York
    • +1 more
    Oct 3, 2022

    Solid Tumor, Colorectal Cancer, Cholangiocarcinoma Trial in France, United States (TRK-950, Irinotecan, Leucovorin)

    Recruiting
    • Solid Tumor
    • +11 more
    • TRK-950
    • +14 more
    • Scottsdale, Arizona
    • +13 more
    Oct 2, 2022

    Bladder Cancer Trial in New York ([68Ga]PSMA, PET/CT imaging)

    Recruiting
    • Bladder Cancer
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Sep 28, 2022

    Urothelial Carcinoma, Bladder Cancer Trial in United States (Placebo, Pembrolizumab)

    Completed
    Has Results
    • Urothelial Carcinoma
    • Bladder Cancer
    • Phoenix, Arizona
    • +27 more
    Sep 16, 2022

    Bladder Cancer, Recurrent Bladder Cancer, FGFR3 Gene Mutation Trial in United States (Erdafitinib)

    Recruiting
    • Bladder Cancer
    • +2 more
    • Basking Ridge, New Jersey
    • +6 more
    Aug 22, 2022

    NSCLC, Renal Cell Cancer, Colorectal Cancer Trial in Australia, United States (CPI-006, CPI-006 + ciforadenant, CPI-006 +

    Active, not recruiting
    • Non-Small Cell Lung Cancer
    • +12 more
    • Tucson, Arizona
    • +26 more
    Aug 1, 2022

    Bladder Cancer Trial in United States (Abemaciclib)

    Recruiting
    • Bladder Cancer
    • Tampa, Florida
    • +3 more
    Jul 27, 2022

    Bladder Cancer Trial in Canada, United States (therapeutic conventional surgery, therapeutic standard lymphadenectomy,

    Active, not recruiting
    • Bladder Cancer
    • therapeutic conventional surgery
    • +2 more
    • Los Angeles, California
    • +34 more
    Jul 20, 2022

    Bladder Cancer, Urothelial Carcinoma, Urothelial Carcinoma Bladder Trial in Worldwide (UGN-102)

    Recruiting
    • Bladder Cancer
    • +2 more
    • Tucson, Arizona
    • +76 more
    Jul 13, 2022